Hedgehog Mushroom

Metadata

Regulatory Status

European Union

• Food status: Long-established traditional food mushroom across Europe. One of the officially recognized edible species sold in French markets. Widely consumed in Scandinavia, Italy, the UK, and Eastern Europe.
• Commercial significance: Commonly sold alongside chanterelles in European markets. Valued for its mild, slightly sweet flavor and firm texture.
• Harvesting: Subject to regional foraging regulations. Generally abundant where present.

United States

• Food status: Recognized as a traditional edible mushroom. Wild-harvested and sold through specialty channels and farmers markets, particularly in the Pacific Northwest.
• Dietary supplement: Not marketed as a dietary supplement.
• FDA GRAS status: No specific GRAS determination.

China and East Asia

• Not listed in the Chinese Pharmacopoeia. Related Hydnum species occur in East Asian forests but are not traditionally emphasized in Chinese or Japanese medicinal traditions compared to Hericium species.

Conditions & Indications

Primary: Anticancer Activity (Preclinical Evidence)

• Repandiol cytotoxicity: The unique compound repandiol, a diepoxide with the structure (2R,3R,8R,9R)-4,6-decadiyne-2,3:8,9-diepoxy-1,10-diol, demonstrates potent cytotoxic activity against multiple tumor cell types. Notably, it shows exceptional activity against colon adenocarcinoma cells with an IC50 of 0.30 ug/mL.
• In vivo anticancer activity: Extracts from fruiting bodies showed 90% inhibition against both Sarcoma 180 and Ehrlich solid cancers in mouse models. Culture mycelial extracts showed 70% inhibition against Sarcoma 180 solid cancer.
• Antimicrobial activity: Acetone extracts demonstrate antibacterial activity against pathogenic bacteria and antifungal activity.

Secondary: Antioxidant Activity (Preclinical Evidence)

• Phenolic antioxidant profile: Ferulic acid and quercetin are the predominant polyphenolic compounds. Acetone extracts demonstrate significant DPPH radical scavenging, reducing power, and metal chelation activity.
• Protective activity: Extracts show protective effects against chemotherapeutic-induced genotoxicity in vitro, suggesting potential cytoprotective applications.
• Nutritional antioxidant contribution: Rich in ergosterol (vitamin D2 precursor), B-vitamins, and dietary minerals (potassium, iron, manganese, zinc) that contribute to overall antioxidant defense.

Emerging/Preclinical: Potential Neurotrophic Activity

• Hydnoid fungi context: Hydnum repandum belongs to the hydnoid (tooth-bearing) fungi group, which includes Hericium erinaceus (Lion’s Mane) — the most thoroughly studied mushroom for nerve growth factor (NGF) stimulation. Cyathane diterpenoids with NGF-stimulating properties have been extensively characterized in Hericium, Cyathus, and Sarcodon genera.
• Status for H. repandum: Direct NGF-stimulating activity or cyathane diterpenoid content has NOT been specifically confirmed for Hydnum repandum. The species contains different chemistry (repandiol, a polyacetylene diepoxide) rather than the cyathane diterpenoids responsible for neurotrophic activity in lion’s mane. [UNCERTAIN: The assignment to cognitive-neuro category is based on taxonomic proximity and preliminary structural analogies rather than direct experimental evidence of NGF stimulation in this species.]
• Research gap: Targeted investigation of H. repandum for neurotrophic metabolites represents an important unfilled research opportunity. [NEEDS-RESEARCH]

Mechanism of Action

Primary Mechanisms

1. Repandiol cytotoxic mechanism: Repandiol acts as a bifunctional alkylating agent via its two epoxide groups. The diepoxide can form covalent bonds with nucleophilic sites on DNA and proteins, potentially cross-linking DNA strands and disrupting replication in cancer cells. The polyacetylenic backbone (4,6-decadiyne) contributes to membrane interactions and selectivity. The specific mechanism of selectivity for colon adenocarcinoma cells is not fully elucidated. [NEEDS-RESEARCH]

2. Phenolic antioxidant activity: Ferulic acid acts as a potent hydroxyl radical scavenger and lipid peroxidation inhibitor through its phenylpropanoid structure with methoxy and hydroxyl substituents. Quercetin provides broad-spectrum antioxidant protection through multiple mechanisms: direct radical scavenging, metal chelation (particularly iron and copper), and inhibition of lipoxygenase and xanthine oxidase enzyme systems.

3. Polysaccharide immunomodulation: Beta-glucan polysaccharides from the fruiting body interact with innate immune receptors (dectin-1, complement receptor 3), enhancing macrophage phagocytic activity and natural killer cell function. This immunomodulatory activity likely contributes to the observed anticancer effects in animal models.

Secondary Mechanisms

• Ergosterol and vitamin D2 pathway: Ergosterol content provides membrane antioxidant function and serves as a precursor to vitamin D2, which modulates immune function and cell proliferation through VDR signaling.
• Genoprotective activity: Extracts demonstrate protective effects against chemotherapy-induced DNA damage, potentially through enhanced DNA repair enzyme expression and free radical scavenging that reduces oxidative DNA lesions.

Clinical Evidence Summary

No human clinical trials have been published for Hydnum repandum for any therapeutic indication. Evidence derives from in vitro studies, chemical characterization, and limited animal models.

Key Research

Evidence Limitations

• No human clinical trials exist for any indication.
• Repandiol cytotoxicity has been demonstrated only in vitro; no in vivo pharmacokinetic or efficacy data exist for this compound.
• The species cannot be commercially cultivated due to obligate ectomycorrhizal ecology, severely limiting research material supply.
• NGF-stimulating activity has NOT been confirmed for H. repandum specifically — this is a critical gap given the cognitive-neuro category assignment.
• Animal anticancer data (Ohtsuka et al., 1973) is historic and would benefit from replication with modern methodologies.
• Wild-harvested specimens show variability in bioactive content by location, season, and host tree association.
• The Hydnum repandum species complex may include multiple cryptic species with different bioactive profiles.

Safety Profile

General Assessment

H. repandum is considered one of the safest wild mushrooms for foraging and consumption. It has no known toxic compounds at normal culinary consumption levels and, critically, has no poisonous lookalikes. The distinctive tooth-like spines on the underside (instead of gills or pores) make it essentially unmistakable. Centuries of safe culinary consumption across Europe provide robust safety evidence.

Contraindications

• Mushroom allergy: Individuals with known allergy to Hydnaceae should avoid consumption.
• Bitter specimens: Older or very large specimens may develop a bitter taste from concentrated terpenoid compounds. While not toxic, these may cause mild gastrointestinal discomfort and are generally trimmed or avoided in culinary preparation.

Drug Interactions

• No documented drug interactions at culinary consumption levels. The absence of documented interactions reflects the lack of clinical studies rather than demonstrated safety at therapeutic doses.

Side Effects

• Common: None at culinary consumption levels.
• Uncommon: Mild bitterness in older specimens, which is unpleasant but not harmful.
• Rare: Allergic reactions in fungal-sensitive individuals.

Toxicology

• No acute or chronic toxicity documented for whole mushroom consumption.
• Repandiol, while cytotoxic to cancer cells in vitro, has not been studied for systemic toxicity in vivo. Any future therapeutic development would require thorough toxicological evaluation.
• The variety H. repandum var. album (white form) contains the same bioactive compounds and has an equivalent safety profile.

Clinical Dosage

No Established Therapeutic Dosage

No human clinical trials have been conducted, so no evidence-based therapeutic dosage recommendations exist.

Culinary Consumption (Nutritional Relevance)

• Typical serving: 50—150 g fresh mushroom per meal
• Caloric content: Approximately 25—35 kcal per 100 g fresh
• Protein content: 2—4 g per 100 g fresh, with complete essential amino acid profile
• Mineral contribution: Significant potassium, phosphorus, magnesium, iron, manganese, and zinc
• B-vitamin contribution: Riboflavin (B2), niacin (B3), pantothenic acid (B5)
• Preparation: Best sauteed in butter; firm texture holds well. Younger specimens preferred for milder flavor.

Research Dosages (Animal Studies, Not for Human Extrapolation)

• Anticancer study (Ohtsuka 1973): Hot water extracts from fruiting bodies administered to mice; specific dosing details in mg/kg not standardized by modern methods
• Note: Preclinical doses cannot be directly extrapolated to human therapeutic doses

Practical Considerations

The obligate mycorrhizal ecology prevents commercial cultivation, making standardized extract production impractical. Mycelial culture has been established under laboratory conditions but has not been scaled to commercial production. Any therapeutic application would require either cultivation breakthroughs, synthesis of repandiol (feasible given its relatively simple structure), or identification of alternative sources.

Sources

• Takahashi A, Endo T, Nozoe S. Repandiol, a new cytotoxic diepoxide from the mushrooms Hydnum repandum and H. repandum var. album. Chem Pharm Bull. 1992;40(12):3181-3184
• Ohtsuka S, Ueno S, Yoshikumi C, et al. Antitumor activity of extracts from Hydnaceae. Chem Pharm Bull. 1973;21(8):1820-1822
• Tubic Grozdanis N, Kosanic M, Rankovic B, et al. Chemical composition, antioxidant activity and cytotoxic effects of Hydnum repandum mushroom. Farmacia. 2019;67(1):174-183
• Pejin B, Teszlak P, Vujisic L, et al. Favourable culture conditions for mycelial growth of Hydnum repandum, a medicinal mushroom. Nat Prod Res. 2013;27(4-5):439-444
• Barros L, Venturini BA, Baptista P, et al. Chemical composition and biological properties of Portuguese wild mushrooms. J Agric Food Chem. 2008;56(10):3856-3862
• Kim MY, Seguin P, Ahn JK, et al. Phenolic compound concentration and antioxidant activities of edible and medicinal mushrooms from Korea. J Agric Food Chem. 2008;56(16):7265-7270
• Grundemann C, Reinhardt JK, Lindequist U. Screening of mushrooms bioactivity: piceatannol was identified as a bioactive ingredient in the order Cantharellales. Eur Food Res Technol. 2018;244(5):861-869

Connections

• Lion’s Mane (Hericium erinaceus): Lion’s Mane is the most thoroughly studied mushroom for nerve growth factor stimulation, producing cyathane diterpenoids (hericenones, erinacines) with well-documented neurotrophic activity. While H. repandum shares the tooth-bearing (hydnoid) morphology, the two genera are phylogenetically distant and produce different bioactive chemistries. Lion’s mane provides the gold standard for mushroom-derived cognitive-neuro applications against which hedgehog mushroom should be compared.
• Coral Tooth (Hericium coralloides): Coral Tooth is another Hericium species with neurotrophic cyathane diterpenoids, reinforcing that NGF stimulation is a Hericium-specific rather than broadly hydnoid trait. Research comparing Hydnum and Hericium metabolomes would clarify whether any neurotrophic overlap exists.
• Chanterelle (Cantharellus cibarius): Chanterelle is a fellow premium wild edible ectomycorrhizal fungus sharing the antioxidant phenolic profile and uncultivatable ecology. Both are among the safest wild mushrooms for beginner foragers.
• King Bolete (Boletus edulis): King Bolete is another premier ectomycorrhizal wild edible with significant antioxidant and nutritional properties, sharing the cultivation constraint that limits medicinal product development.
• Research context: The unique compound repandiol represents an underexplored natural product with promising anticancer selectivity. Its relatively simple structure may be amenable to chemical synthesis, potentially bypassing the cultivation barrier. The question of whether Hydnum repandum produces any neurotrophic metabolites analogous to lion’s mane’s hericenones and erinacines remains one of the most interesting open questions in this species’ pharmacology.